Skip to main content
Clinical Trials/NCT06073561
NCT06073561UnknownNot Applicable

Underwater Endoscopic Mucosal Resection a Learning Curve Study

Instituto Portugues Oncologia de Lisboa Francisco Gentil2 sites in 1 country90 target enrollmentStarted: January 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
90
Locations
2
Primary Endpoint
learning curve of the application of U-EMR by endoscopists skilled in C-EMR

Study Overview

Brief Summary

The global aim of this multi-centric study is to assess the learning curve of U-EMR by an endoscopist skilled in C-EMR aiming to assess the application in real world and check the rate of complete EMR and adverse events related to the procedure.

Detailed Description

Conventional Endoscopic mucosal resection (C-EMR) is currently the standard therapy for the removal of large colon polyps. The procedure consists on the injection of fluids into the submucosa layer below the lesion with the intention to create a cushion to separate it from the muscular layer and avoid its damage and consequently perforation and thermal injury. There are some drawbacks about this technique such us fibrotic polyps, difficult location (areas behind the fold and appendicular orifice) and recurrence rate which without ablation techniques could reach 30%.

Underwater endoscopic mucosal resection (U-EMR) has been first described in 2012 by Binmoeller et al [10] and the main difference to C-EMR was the absence of need the submucosal injection. This would be possible because when the lumen is filled with water, the mucosal and the submucosal layer tend to float while the muscularis propria maintains its circular shape even in the presence of peristalsis. Recent data as shown not only a lower rate of recurrence but also a lower procedure time and R0 resections with no difference in adverse events.

Therefore, the global aim of this multi-centric study is to assess the learning curve of U-EMR by an endoscopist skilled in C-EMR aiming to assess the application in real world and check the rate of complete EMR and adverse events related to the procedure.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: 18 years-old or older with at least one large (>10 and <30 mm) non pedunculated polyp
  • Agreement with study's procedures, having signed the informed consent for the study and EMR, prior to the procedure

Exclusion Criteria

  • Previous attempted resection
  • Lesion located at ileo-cecal valve or appendiceal orifice
  • Fully circumferential lesion
  • Pedunculated polyps (Paris classification type Ip) and ulcerated depression lesions (Paris classification type III)
  • Surface pattern suggestive of deep invasion (ex: narrow-band imaging (NBI) International Colorectal Endoscopic (NICE) classification type 3 criteria, Kudo V or equivalent)
  • Invasive cancer at EMR specimen
  • Inflammatory bowel disease
  • Familial polyposis syndrome

Outcomes

Primary Outcomes

learning curve of the application of U-EMR by endoscopists skilled in C-EMR

Time Frame: 6 months

evaluate the learning curve of the application of U-EMR by endoscopists skilled in C-EMR after an online course about U-EMR technique.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Instituto Portugues Oncologia de Lisboa Francisco Gentil
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Luís Correia Gomes

Medical Degree

Instituto Portugues Oncologia de Lisboa Francisco Gentil

Study Sites (2)

Loading locations...

Similar Trials